Skip to main content
Log in

Screening of HLA-A2 restricted CTL epitopes using molecular simulation

  • Reports
  • Published:
Chinese Science Bulletin

Abstract

A new technology has been established to screen CTL epitope by using molecular simulation and molecular dynamics. By using this technology, four peptides of MAGE-2 were screened and further identified by peptide binding assay and cytotoxic assay. Results showed that three candidate peptides had higher affinity to HLA-A2 molecule and were able to pulse CTL activitiesin vitro in human PBMC. The results indicated that identification of CTL epitopes with computer assistant could overcome the complicated experimental steps, particularly the peptide elution step, and could directly observe peptide-MHC-I compound binding pattern and could be used to screen CTL epitopes quickly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. van Elsas, A., van der Burg, S. H., van der Minne, C. E. et al., Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A* 0201-binding peptides from the Melan-A/MART-1 self antigen, Eur. J. Immunol., 1996, 26(8): 1683–1689.

    Article  Google Scholar 

  2. Bristol, J. A., Schlom, J., Abrams, S. I., Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties, J. Immunol., 1998, 160(5): 2433–2441.

    Google Scholar 

  3. Manici, S., Sturniolo, T., Imro, M. A. et al., Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11, J. Exp. Med., 1999, 189(5): 871–876.

    Article  Google Scholar 

  4. Falk, K., Rotzschke, O., Stefanivic, S. et al., Allete-specific motifs revealed by squencing of self-peptides eluted from MHC molecules, Nature, 1991, 351: 290–296.

    Article  Google Scholar 

  5. Adams, H. P., Koziol, J. A., Prediction of binding to MHC class I molecules, J. Immunol. Methods, 1995, 185(2): 181–190.

    Article  Google Scholar 

  6. Sun, M., Che, Y., Miao, F. M. et al., Conformational analysis on anti-HIV-1 peptide T22([Tyr5,12,Lys7]-polyphemusinII), Chinese Science Bulletin, 2001, 46(20): 1685–1688.

    Article  Google Scholar 

  7. De Backer, O., Verheyden, A. M., Boon, T., Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes, Genomics, 1995, 28(1): 74–83.

    Article  Google Scholar 

  8. Weynants, P., Lethe, B., Brasseur, F. et al., Expression of mage genes by non-small-cell lung carcinomas, Int. J. Cancer, 1994, 56(6): 826–829.

    Article  Google Scholar 

  9. Tahara, K., Mori, M., Sadanaga, N. et al., Expression of the MAGE gene family in human hepatocellular carcinoma, Cancer, 1999, 85(6): 1234–1240.

    Article  Google Scholar 

  10. Scarcella, D. L., Chow, C. W., Gonzales, M. F. et al., Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers, Clin-Cancer-Res., 1999, 5(2): 335–339.

    Google Scholar 

  11. Dalerba, P., Frascella, E., Macino, B. T. et al., MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas, Int-J-Cancer, 2001, 93(1): 85–90.

    Article  Google Scholar 

  12. Visseren, M. J., van der Burg, S. H., van der Voort, E. I. et al., Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product, Int. J. Cancer, 1997, 73(1): 125–130.

    Article  Google Scholar 

  13. Geng, M., Jia, Z. C., Wan, Y. et al., Prediction of HLA-A2 restricted CTL epitope of tumor antigen MAGE-2, Acta Academiae Medicinae Militaris Tertiae (in Chinese), 2000, 22(10): 934–937.

    Google Scholar 

  14. Nijman, H. W., Houbiers, J. G., Vierboom, M. P. et al., Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes [J], Eur. J. Immunol., 1993, 23(6): 1215–1219.

    Article  Google Scholar 

  15. Yoon, H., Chung, M. K., Min, S. S. et al., Synthetic peptides of human papillomavirus type 18 E6 harboring HLA-A2 motif can induce peptide-specific cytotoxic T-cell from peripheral blood mononuclear cell, Virus Research, 1998, 54: 23–29.

    Article  Google Scholar 

  16. Matsumura, M., Fremont, D. H., Peterson, P. A. et al., Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science, 1992, 257(5072): 927–935.

    Article  Google Scholar 

  17. Lim, J. S., Kim, S., Lee, H. G. et al., Selection of peptides that bind to the HLA-A2 molecule by molecular modeling. Molecular Immunlogy, 1996, 33(2): 221–230.

    Article  Google Scholar 

  18. McCammon, J. A., Harvey, S. C., Dynamics of protein and nucleic acid, London: Cambridge University Press, 1987, 150–270.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuzhang Wu.

About this article

Cite this article

Geng, M., Wu, Y., Lin, Z. et al. Screening of HLA-A2 restricted CTL epitopes using molecular simulation. Chin. Sci. Bull. 48, 1962–1966 (2003). https://doi.org/10.1007/BF03183987

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03183987

Keywords

Navigation